Novartis/BeiGene Opt For PD-1/TIGIT Combo For NSCLC In US

Defocus On 2L Monotherapy

 
• By Dexter Jie Yan
Novartis/BeiGene to shift gears
Novartis/BeiGene shift US clinical strategy for non-small cell lung cancer • Source: Shutterstock

More from China

More from Focus On Asia